The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL). Despite the use of newer agents, such as polatuzumab vedotin, more than one-third of patients have ultimately relapsed or experienced refractory disease. MiRNAs are single-stranded, ~22-nucleotide-long RN...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-11-01
|
| סדרה: | Biomedicines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2227-9059/12/12/2658 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
